Furthermore, the in vivo tumorigenic assays revealed that the overexpression of PLA2R1 could inhibit the growth and proliferation of the thyroid tumor by modulating the ITGB1/FAK-signaling axis, compared to the control group in the animal study. This evidence concerns the gene PTK2 and thyroid tumor.